208 related articles for article (PubMed ID: 7717094)
1. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Priest RG; Gimbrett R; Roberts M; Steinert J
Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
[TBL] [Abstract][Full Text] [Related]
2. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
Liebowitz MR; Hollander E; Schneier F; Campeas R; Welkowitz L; Hatterer J; Fallon B
Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Lotufo-Neto F; Trivedi M; Thase ME
Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
[TBL] [Abstract][Full Text] [Related]
5. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
7. Medication treatments for panic disorder and social phobia.
Stein MB
Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
[TBL] [Abstract][Full Text] [Related]
8. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
Nair NP; Ahmed SK; Kin NM; West TE
Acta Psychiatr Scand Suppl; 1995; 386():28-35. PubMed ID: 7717092
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch KP; Struck M; Beckmann H
J Neural Transm Suppl; 1990; 32():189-95. PubMed ID: 2089089
[TBL] [Abstract][Full Text] [Related]
10. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide in the treatment of social phobia.
Nutt D; Montgomery SA
Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():77-82. PubMed ID: 8923114
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Delini-Stula A; Mikkelsen H; Angst J
J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
[TBL] [Abstract][Full Text] [Related]
14. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide in social phobia: a controlled dose-response trial.
Noyes R; Moroz G; Davidson JR; Liebowitz MR; Davidson A; Siegel J; Bell J; Cain JW; Curlik SM; Kent TA; Lydiard RB; Mallinger AG; Pollack MH; Rapaport M; Rasmussen SA; Hedges D; Schweizer E; Uhlenhuth EH
J Clin Psychopharmacol; 1997 Aug; 17(4):247-54. PubMed ID: 9241002
[TBL] [Abstract][Full Text] [Related]
16. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
Bakish D
J Clin Psychopharmacol; 1994 Feb; 14(1):74-5. PubMed ID: 8151007
[No Abstract] [Full Text] [Related]
17. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
Da Prada M; Keller HH; Kettler R
Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide--placebo-controlled trials.
Silverstone T
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
[TBL] [Abstract][Full Text] [Related]
20. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
Tiller JW; Bouwer C; Behnke K
Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
